Literature DB >> 20634078

4''-O-(omega-Quinolylamino-alkylamino)propionyl derivatives of selected macrolides with the activity against the key erythromycin resistant respiratory pathogens.

A Fajdetić1, H Cipcić Paljetak, G Lazarevski, A Hutinec, S Alihodzić, M Derek, V Stimac, D Andreotti, V Sunjić, J M Berge, S Mutak, M Dumić, S Lociuro, D J Holmes, N Marsić, V Eraković Haber, R Spaventi.   

Abstract

Four macrolides-6-O-methyl-8a-aza-8a-homoerythromycin, clarithromycin, azithromycin and azithromycin 11,12-cyclic carbonate, have been selected for the construction of a series of new quinolone derivatives. The quinolone moiety is connected to the macrolide scaffold via a diaminoaklyl 4''-O-propionyl ester chain of varying length. At the terminus the linker is attached via one of the nitrogen atoms in the linker at C(6) or C(7) of the quinolone. Many of compounds described, particularly clarithromycin derivative 37, and azithromycin derivatives 48 and 55, exhibited excellent antibacterial activity against a wide range of clinically relevant macrolide-resistant organisms, with profiles superior to that of telithromycin, an enhanced spectrum ketolide. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634078     DOI: 10.1016/j.bmc.2010.06.049

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo.

Authors:  Hana Čipčić Paljetak; Donatella Verbanac; Jasna Padovan; Miroslava Dominis-Kramarić; Željko Kelnerić; Mihaela Perić; Mihailo Banjanac; Gabrijela Ergović; Nerrisa Simon; John Broskey; David J Holmes; Vesna Eraković Haber
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

2.  Discovery of 4''-ether linked azithromycin-quinolone hybrid series: influence of the central linker on the antibacterial activity.

Authors:  Dražen Pavlović; Stjepan Mutak
Journal:  ACS Med Chem Lett       Date:  2011-03-15       Impact factor: 4.345

Review 3.  From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials.

Authors:  Dubravko Jelić; Roberto Antolović
Journal:  Antibiotics (Basel)       Date:  2016-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.